Patient managed clinical trial

Controlled Clinical Trials

Volumn 18, Issue 2, 1997, Pages 140-150

  Hokkanen, Tiina ^a   Hemminki, Elina ^e   Aalto, Pirjo ^b   Hakama, Matti ^a   Huhtala, Heini ^a   Jylhä, Marja ^a   Karjalainen, Sakari ^c   Tuimala, Risto ^d  

^a UNIVERSITY OF TAMPERE   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c ACADEMY OF FINLAND   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

compliance; managed clinical trial; noncompliance; postmenopausal hormone therapy

Indexed keywords

HORMONE; PLACEBO;

ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEALTH SERVICE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PHYSICIAN; POSTMENOPAUSE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

CHI-SQUARE DISTRIBUTION; DATA INTERPRETATION, STATISTICAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FINLAND; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; PILOT PROJECTS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0030923818     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00113-4     Document Type: Article

References (21)

1. Hemminki E. Use of combined estrogen-progestin replacement therapy - an example of the dissemination of new indications for an old technology. Int J Technol Assess Health Care 1988;4:511-519.
2. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
3. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993;46:211-219.
4. Posthuma WFM, Westendop RGJ, Vandenbroucke JP: Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? Br Med J 1994;308:1268-1269.
5. Hemminki E, Sihvo S. A review of postmenopausal hormone therapy recommendations: potential for selection bias? Obstet Gynecol 1993;82:1021-1027.
6. Meade TW, Berra A. Hormone replacement therapy and cardiocascular disease. Br Med Bull 1992;48:270-308.
7. Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. Br Med J 1992;305:1403-1408.
8. Cochrane AC. Effectiveness and efficiency. Random reflections on health services. Nuffield Provincial Hospital Trust, 1972.
9. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991;32:35-42.
10. Gøtzsche PC. Is there logic in the placebo? Lancet 1994;344:925-926.
11. Chaput de Saintonge DM, Herxheimer A. Harnessing placebo effects in health care. Lancet 1994;344:995-998.
12. Kleijnen J, de Craen AJM, van Everdingen J, Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 1994;344:1347-1349.
13. McPherson K. The best and the enemy of the good: randomized controlled trials, uncertainty and assessing the role of patient choice in medical decision making. J Epidemiol Community Health 1994;48:6-15.
14. Linder A. Planen und Antwerten von versuchen, p. 329. Birkhaüser, Basle 1969. Reprinted in Geigy Scientific Tables part 2, p. 167. Ciba-Geigy Limited, Basle 1982.
15. Linder A. Planen und Antwerten von versuchen, p. 329. Birkhaüser, Basle 1969. Reprinted in Geigy Scientific Tables part 2, p. 167. Ciba-Geigy Limited, Basle 1982.
16. Hemminki E, Topo P, Malin M, Kangas I. Physicians' views on hormone therapy around and after menopause. Maturitas 1993;16:163-173.
17. Lumley J. Does this work? Pediatrics 1987;79:1040-1044.
18. Tognoni G, Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, Marchioli R, Zussino A. Randomized clinical trials in general practise: lessons from a failure. Br Med J 1991;303:969-971.
19. Langley GR, Surherland HJ, Wong S, Minkin S, Llewellyn-Thomas HA, Till JE. Why are (or are not) patients given the option to enter clinical trials? Controlled Clin Trials 1987;8:49-59.
20. Mattson ME, Curb JD, McArdle R. AMIS and BHAT Research Groups. Participation in a clinical trial: the patient's point of view. Controlled Clin Trials 1985;6:156-167.
21. Elbourne D: Subjects' views about participation in a randomized controlled trial. J Reproduc Infant Psych 1987;5:3-8.